Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction

Abstract

Ranolazine protects against experimental doxorubicin cardiotoxicity. Such protection is accompanied by a reduction in oxidative stress, suggesting that INa modulates cardiac redox balance, resulting in functional and morphological derangements.